Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by ledzep4uon Dec 10, 2018 12:26pm
121 Views
Post# 29092134

Canopy and Big Tobacco

Canopy and Big Tobacco I've been trying to understand how big tobacco would be of benefit to Canopy. I know Bruce has said that it was just a matter of time for them to get involved because MJ would be a tobacco disruptor, but I'm not sure it would specifically benefit Canopy for the following reasons:

1. Altria invested in Cronos to diversify itself away from tobacco because sales in the US are droppping each year, but are growing in foreign countries. I see it more of an invesment than a partnership. As Cronos expands and grows in revenues/market value then Altria's balance sheet looks that much better through its investment. Eventually, like Constellation, they could control the comapny. 

2. If tobacco invests in an LP as a partnership, what do they bring to the table besides financing?  Tobacco does understand the marketing and distribution rules as they are pretty much the same as MJ in Canada, but what else? Most tobacco comapnies buy their tobacco from farmers and they don't have retail outlets selling their tobacco producrs and accessories as it's mostly sold in convenience stores.

3. The Canadian model and what is mostly happening in the US are companies setting up retail shops to sell various MJ products or there own products if they are a LP. Canopy has retail outlets in most parts of Canada such as Tokoyo Smoke. It will have a retail presence in Ontario come April 1, but it will be legally structured to meet the 9.9% affiliated rule. One avenue may be by franchising retail stores to get around the 9.9% rule, but I'll leave that to much smarter corporate lawyers. Again, I don't see tobacco adding value.

4. In Canopy's case, I don't see a benefit and there may also be Constellation agreement rules that prevent it. Remember, Constellation paid for warrants in the $5B deal that allow it to take specific future ownership % positions with the 2 future deals. If Canopy enters into an agreement with a big tobacco company, it will likely be through an investment which means selling shares to them and further diluting Canopy shares. This would mean that Constellation would then have to buy more shares to acquire the same specific ownership % which I don't believe can happen because of the Constellation agreement and specific number of warrants that were purchased.

5. The last purchase that Canopy made for Storz & Bickel was all cash. I believe most, if not all, future major acquistions will be all cash to prevent further dilution as per the Constellation agreement. They gave Canopy $5B so they could expand and not dilute. If they are allowed to dilute, I'm sure there are clauses in the agreement that benefit Constellation so as not to change their future ownership % position if and when they decide to exercise their warrants. 

Just my thoughts and I welcome any constructive arguments or addtional thoughts. GLTA

Bullboard Posts